Yarrow Bioscience, Inc.
YARW· Nasdaq
Released Feb 27, 2019, after the close
10-K filed Feb 28, 2019, 59 days after period end · 0001564590-19-005451
| Metric | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|
| Revenue | $3.60M | $2.78M | — |
| Net Income | -$17.59M | -$9.28M | -$4.84M |
| EPS Diluted | -$0.76 | -$1.80 | -$0.96 |
Yarrow Bioscience, Inc. · CIK 1566044 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.